Skip to main content
. Author manuscript; available in PMC: 2020 Sep 9.
Published in final edited form as: Semin Arthritis Rheum. 2019 Jun 3;49(2):267–272. doi: 10.1016/j.semarthrit.2019.05.010

Table 2:

Predictors of Steroid-related Damage^ in cSLE as compared to aSLE among 1035 participants in Lupus Outcomes Study

Multivariate Analyses
Model 1 Model 2
OR (95% Cl) OR (95% Cl)
cSLE 2.04 (1.30,3.30)* 1.70 (1.10,2.80)*
Demographics
Age at baseline 1.08 (1.06,1.09)* 1.07 (1.06,1.09)*
Sex
 Male (reference)
 Female 1.10 (0.70,1.90)
Ethnicity
 Caucasian (reference)
 Hispanic 0.90 (0.60,1.40)
 African American 1.80 (1.1,2.9)*
 Asian 1.30 (0.80,2.00)
 Other 1 (0.50,1.80)
SLE-related characteristics
Disease duration category
 0–10 yrs (reference)
 10–20 years 1.70 (1.20,2.30)*
 >20 years 1.80 (1.20, 2.70)*
Cyclophosphamide use 2.30 (1.50,3.40)*
Steroid use 3.62 (1.80,7.25)* 2.90 (1.40,5.80)*
^

Steroid-related damage is defined as one of the following: cataract, osteoporosis resulting fracture, avascular necrosis, diabetes.

OR=odds ratio

*

P<0.05

Model 1: calculated from logistic regression results, adjusted for age at baseline BILD score and steroid use.

Model 2: calculated from logistic regression results, adjusted for baseline age, steroid use ever, demographics (sex, ethnicity) and SLE-related predictors (disease duration, cyclophosphamide use ever).